Clinical trial
Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With…
NCT00004387 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004387 |
|---|---|
| Title | Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Icahn School of Medicine at Mount Sinai |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Procedure |
| Interventions | fetal nigral transplantation |
| Enrollment | 34 |
| Start date | Jan 1, 1996 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: